{"id":"W4223938136","doi":"10.1002/cncr.34195","title":"Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Sierra Oncology; Sociedad Española de Hematología y Hemoterapia; Astellas Pharma; Incyte; AstraZeneca; Celgene; Sanofi","keywords":"Medicine; Ruxolitinib; Polycythemia vera; Internal medicine; Myelofibrosis; Intensive care medicine; Bone marrow","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004349288,0.0003165211,0.0006448053,0.0009323814,0.000201355,0.000966014,0.000504353,0.0005473134,0.001123407],"category_scores_gemma":[0.010888,0.0002533073,0.001229342,0.001266958,0.0004329417,0.0005441479,0.0005758985,0.0005443586,0.0001674542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008114912,"about_ca_system_score_gemma":0.0003576299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001736724,"about_ca_topic_score_gemma":0.001147866,"domain_scores_codex":[0.9962516,0.002293773,0.0003156234,0.0006938282,0.0002537552,0.0001912685],"domain_scores_gemma":[0.9839054,0.005000757,0.008532622,0.001284849,0.0006302187,0.0006461139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002444563,0.00007672998,0.9928397,0.0000669653,0.0009973934,0.0001167671,0.00004593994,0.001155869,0.0001136355,0.00007363613,0.0003094398,0.001759402],"study_design_scores_gemma":[0.0002342536,0.0007581567,0.9920835,0.00003057276,0.0004366916,0.0005981454,0.0001789775,0.004633112,0.0001475103,0.0001743475,0.0006970486,0.0000277861],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970785,0.0005223753,0.0003368851,0.00005740775,0.0000101352,0.00002137974,0.001772689,0.000003377492,0.0001973133],"genre_scores_gemma":[0.9971216,0.0001006245,0.0001761375,0.00002806171,0.00001384382,0.00002506752,0.002497531,0.000002252611,0.00003492949],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004349288,"threshold_uncertainty_score":0.02300155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03460510078697988,"score_gpt":0.3338272260981437,"score_spread":0.2992221253111638,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}